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Aim: This study investigates whether a local renin–angiotensin system
(RAS) exists in mouse colon and whether angiotensin II (Ang II) may play
a role in the regulation of the contractile activity.
Methods: Isometric recordings were performed in vitro on the longitudi-
nal muscle of mouse proximal and distal colon. Transcripts encoding for
RAS components were investigated by RT-PCR.
Results: Ang II caused, in both preparations, a concentration-dependent
contractile effect, antagonized by losartan, AT1 receptor antagonist, but
not by PD123319, AT2 receptor antagonist. The combination of losartan
plus PD123319 caused no change on the Ang II-induced contraction than
losartan alone. Tetrodotoxin, neural blocker, reduced the contractile
response to Ang II in the proximal colon, whilst the response was abol-
ished in the distal colon. In both preparations, atropine, muscarinic recep-
tor antagonist, or SR140333, NK1 receptor antagonist, reduced the Ang II
responses. Ondansetron, 5-HT3 receptor antagonist, SR48968, NK2 recep-
tor antagonist, or hexamethonium, nicotinic receptor antagonist, were
ineffective. The joint application of atropine and SR140333 produced no
additive effect. Atropine reduced NK1-induced contraction. Transcripts
encoding RAS components were detected in the colon samples. However,
just AT1A mRNA was expressed in both preparations, and AT2 mRNA
was expressed only in the distal colon.
Conclusion: In the murine colon, local RAS may play a significant role in
the control of contractile activity. Ang II positively modulates the
spontaneous contractile activity via activation of post-junctional and
pre-junctional AT1A receptors, the latter located on the enteric neurones,
modulating the release of tachykinins and acetylcholine.
Keywords angiotensin II, AT1 receptors, AT2 receptors, enteric neurones,
mouse colon, muscle contraction.
Angiotensin II (Ang II), the major bioactive compo-
nent of the renin–angiotensin system (RAS), induces a
multitude of events contributing to the regulation of
blood pressure, body fluid volume and electrolyte bal-
ance. Traditionally, RAS is regarded as an endocrine
system, but its components can be found in several
tissues, indicating also paracrine–autocrine functions
(Paul et al. 2006, Fyhrquist & Saijonmaa 2008). Two
main Ang II receptors have been described, namely
AT1 and AT2, receptors, both members of the G-
protein-coupled receptor family (De Gasparo et al.
2000). The rat and mouse AT1 receptors exist as two
© 2012 The Authors
Acta Physiologica © 2012 Scandinavian Physiological Society, doi: 10.1111/apha.12041 337
Acta Physiol 2013, 207, 337–345
distinct subtypes, termed AT1A and AT1B, which are
95% identical in their amino acid sequences. The two
subtypes are also similar in terms of their ligand bind-
ing and activation properties but differ in their tissue
distribution, chromosomal localization, genomic struc-
ture and transcriptional regulation (De Gasparo et al.
2000). The AT1 receptor mediates all classical actions
of Ang II in cardiovascular, renal, neuronal, endo-
crine, hepatic and other target cells. These actions
contribute to the maintenance of arterial blood pres-
sure, electrolyte and water balance, thirst, renal func-
tion and structural remodelling of cardiovascular
tissue (De Gasparo et al. 2000, Jackson 2001). AT2
receptors, on the other hand, have been suggested to
counterbalance most effects that Ang II exerts through
the AT1 receptors (Volpe et al. 2003).
Compared to the cardiovascular, renal and central
nervous systems, there are only few studies on the
role of RAS in the gastrointestinal tract, although
intestinal smooth muscle, ion and fluid transporting
epithelia and host defence cells, all have the potential
to be targets for RAS-mediated regulation. The pres-
ence of Ang II receptors at various levels along the
GI tract has been demonstrated in human, guinea-pig
and rat (Wang et al. 2005, Ewert et al. 2006, Spak
et al. 2008), suggesting a potential physiological
action. In particular, Ang II has been reported to reg-
ulate intestinal fluid and electrolyte transport
(F€andriks 2010, 2011). Because intestinal motility has
consequent impact on intestinal transit (Nylander
2011), the possibility that Ang II would modulate
contractility can be suggested. Indeed, early studies
have shown that Ang II induces contractile responses
in the longitudinal muscle of guinea-pig small intes-
tine, via activation of neural AT1 receptor, which
mediates the release of acetylcholine and substance P,
and AT1 receptor located on smooth muscle cells
(Hawcock & Barnes 1993). Subsequently, the expres-
sion of AT1 receptor protein and the mRNA tran-
script for AT1 receptors in the guinea-pig enteric
nervous system has been confirmed (Wang et al.
2005). Indeed, Ang II-induced contractions primarily
mediated through AT1 receptors located on the mus-
culature have been pharmacologically characterized in
isolated human and rat small intestine (Ewert et al.
2006, Spak et al. 2008) and in human oesophagus
(Casselbrant et al. 2007).
Thus, in consideration that the role of Ang II in the
bowel motility is far from being clear, the aim of this
study was to pharmacologically analyse the effects of
Ang II on mouse proximal and distal colon contractil-
ity, to characterize the subtype(s) of receptor(s)
involved and to investigate the action mechanism.
Moreover, the eventual existence of a local RAS in
mouse colon was investigated by RT-PCR.
Materials and methods
Animals
The study is conforming to Good Publishing Practice
in Physiology (Persson & Henriksson 2011). Experi-
ments were performed on adult male mice (C57BL/
10SnJ; weighing 25.5  0.5 g; Charles River Labora-
tories, Calco-Lecco, Italy). Animals were killed by
cervical dislocation, and after a midline laparotomy,
the entire colon was removed (about 15 cm length)
and placed in Krebs solution (in mM: NaCl 119; KCl
4.5; MgSO4 2.5; NaHCO3 25; KH2PO4 1.2, CaCl2
2.5, glucose 11.1).
Recording of mechanical activity
Mechanical activity of isolated intestinal segments
was recorded as previously described (Zizzo et al.
2006, Baldassano et al. 2009). This experimental
approach was chosen to study the muscle function
under conditions where the influence of external fac-
tors is removed, but the muscle itself performs in a
manner analogous to its in vivo capacity. Briefly, lon-
gitudinally oriented segments (about 20 mm in
length) from proximal (immediately distal to the cae-
cum) or distal (about 5 mm proximal to the anus)
colon were suspended in a 10-mL organ bath wells
with oxygenated (95% O2 and 5% CO2) Krebs solu-
tion (37 °C), anchored at the distal end to an organ
holder and at the proximal end secured with a silk
thread to a force transducer (FORT 10, Ugo Basile,
Biological Research Apparatus, Comerio VA, Italy)
for isometric recording of muscular activity (Power-
Lab/400 system, Ugo Basile, Italy). Preparations,
200 mg preloaded, were allowed to equilibrate for at
least 30 min to develop rhythmic spontaneous con-
tractions. Then, preparations were challenged with
0.1 lM isoproterenol or with 10 lM carbachol (CCh)
until stable responses were obtained. The amplitude
of the relaxation induced by isoproterenol in
proximal colon was 0.19  0.04 g (n = 48) and in
distal colon was 0.23  0.07 g (n = 48). The
contractile response to CCh in proximal colon was
1.35  0.12 g (n = 48) and in distal colon was
1.32  0.19 g (n = 48).
Non-cumulative concentration–response curves for
Ang II, in the absence or in the presence of AT recep-
tor antagonists, were constructed by addition of Ang
II for approximately 5 min at 1-h intervals.
In a second set of experiments, a submaximal dose
of Ang II (1 nM) was used to determine the effects of
tetrodotoxin (TTX), atropine, hexamethonium,
ondasetron, SR 140333 and SR48968.
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Solution and drugs
Drugs used were atropine sulphate, carbamylcholine
chloride (carbachol, CCh), hexamethonium bromide,
isoproterenol, ondansetron hydrochloride dehydrate and
TTX from Sigma-Aldrich Inc. (St Louis, MO, USA);
angiotensin II, 1-[[4-(Dimethylamino)-3-methylphenyl]
methyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imi-
dazo[4,5-c] pyridine-6-carboxylic acid ditrifluoroace-
tate (PD123319) and 2-Butyl-4-chloro-1-[[2′-(1H-
tetrazol-5-yl)-[1,1′-biphenyl]-4-yl]methyl]-1H-imidaz-
ole-5-methanol potassium salt (losartan) from Tocris
Bioscience (Bristol, UK); (S)-N-methyl-N[4-(4-acetyl-
amino-4-phenylpiperi-dino)-2-(3,4-dichloro-phenyl) butyl]
benzamide (SR48968) and (S)-1-[2-[3-(3,4-dichlorphe-
nyl)-1 (3-isopropoxy-phenylacetyl) piperidin-3yl]
ethyl]-4-phenyl-1 azaniabicyclo[2.2.2] octane chloride
(SR140333) were gifts from Sanofi Recherche (Mont-
pellier Cedex, France); [Sar9, Met (O2)
11]-substance P
was from Calbiochem-Novabiochem (Laufelfingen,
Switzerland). SR48968 and SR140333 were dissolved
in dimethyl sulphoxide (0.1% final concentration), and
[Sar9, Met (O2)
11]-substance P was dissolved in diluted
acetic acid. All the other drugs were dissolved in dis-
tilled water. Working solutions were then dissolved in
Krebs solution.
RNA preparation and RT-PCR analysis
Total RNA was extracted from whole thickness proxi-
mal and distal colon, and cDNA was prepared as pre-
viously described (Zizzo et al. 2011). The
oligonucleotide primers for amplification of cDNA
(30 ng per reaction) encoding for angiotensin II type 1
subtype A and B receptors (AT1A, AT1B), angiotensin
II type 2 receptor (AT2), angiotensinogen (AGT),
angiotensin-converting enzyme (ACE), renin and
b-actin were designed from published mouse cDNA
sequences and are summarized in Table 1. PCR analy-
sis was performed in triplicate. Each PCR cycle con-
sisted of denaturing at 94 °C for 45 s, annealing at
56 °C (AT1A receptor, AGT and b-actin) for 60 s or
at 48 °C (AT1B receptor and ACE) for 45 s or 58 °C
(renin) for 45 s or 40 °C (AT2 receptor) for 60 s and
extension at 72 °C for 1 min. This was repeated for
35 cycles, followed by extension at 72 °C for 15 min.
The amplimers were separated on a 1.8% agarose gel
containing 0.5 lg mL1 of GelStar Nucleic Acid Gel
Stain (Lonza Rockland, ME USA) for visualization.
Statistical analysis
All data are presented as means  SEM: ‘n’ indicates
the number of animal preparations. Contractile
responses induced by Ang II were reported as a per-
centage of the effect induced by 10 lM CCh. Ang II
responses were fitted to sigmoid curves (Prism 4.0,
Graph-PAD, San Diego, CA, USA), and EC50 values
with 95% confidence limits (CLs) were determined.
Antagonist potency was expressed as the negative log-
arithm of the concentration of the antagonist required
to cause a twofold rightward shift of the agonist dose
–response curve (pA2 value), calculated by nonlinear
regression analysis of the individual dose–response
curves. Statistically significant differences were calcu-
lated by Student’s t-test or by analysis of variance fol-
lowed by Bonferroni’s test. P < 0.05 was considered
statistically significant.
Results
Intestinal muscle contractility in vitro
Ang II (0.001–100 nM) induced, concentration depen-
dently, a contractile effect in both preparations, with
similar potency (proximal colon: EC50: 0.08 nM, 95%
Table 1 Primer sequences for reverse transcription–polymerase chain reaction (RT-PCR)
RAS component Primer sequences Fragment size
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Cls 0.03–0.23 nM, n = 12; distal colon:
EC50 = 0.05 nM, 95% Cls 0.02–0.09 nM, n = 12)
(Fig. 1–3). At the dose of 10 nM, the maximal response
was observed, being in absolute values
958.5  15.0 mg (n = 12) in proximal and
765.5  18.2 mg (n = 12) in distal colon. An inhibi-
tory/relaxant effect induced by Ang II was never
observed, at any concentration tested. The responses to
Ang II were antagonized in a concentration-dependent
fashion (pA2 = 9.8  0.05 and 10.1  0.02) by losar-
tan, AT1 receptor antagonist (Fig. 2), whilst
PD123319 (up to 0.1 lM), AT2 receptor antagonist,
was without any effect (Fig. 3). AT receptor antago-
nists had no effects on the spontaneous activity. The
combination of losartan (10 nM) plus PD123319
(0.1 lM) showed identical results to those of losartan
alone (Fig. 3).
The neural toxin, TTX (1 lM), reduced the contrac-
tile response to a submaximal dose of Ang II (1 nM)
in the proximal colon, whilst abolished it in the distal
colon (Fig. 4).
To characterize the neural pathway(s) mediating the
indirect (TTX-sensitive) contractile effect induced by
activation of AT1 receptors, Ang II was tested in the
presence of antagonists for cholinergic, serotoninergic
or tachykinergic receptors, the main excitatory system
involved in the control gut motility. Atropine (1 lM),
muscarinic receptor antagonist, or SR140333
(0.1 lM), NK1 receptor antagonist, reduced the
excitatory effects induced by Ang II (1 nM) in both
proximal and distal colon (Fig. 4). On the contrary,
ondansetron (0.1 lM), 5-HT3 receptor antagonist,
SR48968 (0.1 lM), NK2 receptor antagonist, or hexa-
methonium (30 lM), nicotinic receptor antagonist,
were ineffective (Fig. 4). No differences were found in
the effects induced by TTX, atropine and SR140333
on Ang II responses. Moreover, the combination of
atropine (1 lM) and SR 140333 (0.1 lM) produced no
additive effect (Fig. 4). None of the antagonists used
had any significant influence on the spontaneous con-
tractile activity.
Lastly, as shown in Fig. 5, atropine (1 lM) signifi-
cantly reduced the contraction evoked by a specific
NK1 receptor agonist, [Sar
9, Met(O2)
11]-substance
P (1 lM), whilst SR140333 (0.1 lM) failed to affect the
contraction evoked by CCh (10 lM) in distal colon.
Same results were obtained in the proximal colon.
Transcripts encoding RAS components in proximal and
distal colon
Transcripts encoding renin, AGT, ACE and AT1A
receptors were found in the whole thickness prepara-
tions (Fig. 6). AT1B mRNA was not expressed in both
preparations, whilst AT2 mRNA was expressed just in
the distal colon (Fig. 6).
Figure 1 Original recordings showing the mechanical responses evoked by CCh, isoproterenol (ISO) or Ang II in mouse proxi-
mal and distal colon.
© 2012 The Authors
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Discussion
Ang II, the main effector peptide in the renin–Ang sys-
tem (RAS), is known to elicit a wide range of diverse
cellular responses, including growth, proliferation and
vascular smooth muscle contraction. It has gradually
become evident that in addition to the ‘circulating
RAS’, there is also a ‘local RAS’ able to generate all
bioactive Ang peptides in several tissues and organs,
making RAS also a paracrine–autocrine system (Paul
et al. 2006, Fyhrquist & Saijonmaa 2008).
Ang II acts via cell surface receptors subdivided into
AT1 or AT2 type, characterized using selective ligands
(De Gasparo et al. 2000). In rodents, two isoforms of
the AT1 receptor are expressed, termed AT1A and
AT1B. AT1A receptors occur predominantly in vascular
smooth muscle cells, liver, lung and kidney, whereas
AT1B can be found mainly in adrenal and anterior
pituitary (Johren et al. 2003). AT2 receptors are
expressed at certain locations in the adult organisms
such as in the adrenal gland, brain and myocardium
as well as in the vasculature (Fyhrquist & Saijonmaa
2008). Data from our experiments indicate that in
mouse colon, a local RAS system exists supporting a
local action played by Ang II (and its receptors) in the
regulation of the gastrointestinal function. Moreover,
evidence suggests that RAS dysfunction may potenti-
ate immune-based diseases such as IBD, raising the
possibility that local RAS system may become a
potential therapeutic target in a various gastrointesti-
nal diseases (Garg et al. 2012).
Thus, considering that the actions Ang II on gastroin-
testinal wall musculature have not been thoroughly
investigated, we aimed to investigate whether or not
Ang II could be considered a modulator of the sponta-
neous intestinal motor activity using as experimental
Figure 2 Concentration–response curves to Ang II before and after different concentrations of losartan, AT1 receptor antagonist
(n = 4 each), in mouse proximal and distal colon. Data are means  SEM and are expressed as percentage of the maximal effect
induced by 10 lM CCh. The values for the control curves are the means of the control data obtained before each treatment
(n = 12 for both proximal and distal colon). * P < 0.05 when the concentration–response curves were compared to those
obtained in the respective control condition.
Figure 3 Concentration–response curves to Ang II before and after PD123319 (0.1 lM, n = 3), AT2 receptor antagonist, losar-
tan (10 nM, n = 3), AT1 receptor antagonist or PD123319 plus losartan (n = 3) in mouse proximal and distal colon. Data are
means  SEM and are expressed as percentage of the maximal effect induced by 10 lM CCh. The values for the control curves
are the means of the control data obtained before each treatment (n = 9 for both proximal and distal colon).* P < 0.05 when
the concentration–response curves were compared to those obtained in the respective control condition.
© 2012 The Authors
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model the longitudinal muscle of mouse colon. Our
experiments showed a concentration-dependent con-
tractile effect in response to Ang II in both proximal
and distal colon. The concentration–response curve
was significantly shifted to the right by the AT1 recep-
tor antagonist losartan, indicating an AT1 receptor–
mediated effect. The calculated pA2 values are in line
with other reports (Schambye et al. 1994, De Godoy &
De Oliveira 2002). Moreover, Ang II effects were unaf-
fected by the AT2 receptor antagonist, PD123319.
These observations are in agreement with the previous
studies in the human oesophageal muscle (Casselbrant
et al. 2007), in the guinea-pig, rat and human small
intestine (Hawcock & Barnes 1993, Ewert et al. 2006,
Spak et al. 2008) and in the guinea-pig stomach (Lu
et al. 2011) where AT1 receptors are known to mediate
mainly Ang II excitatory effects. Due to the results
obtained by RT-PCR, it appears that the AT1 receptors
subserving contractile effects belong to the subclass of
AT1A receptors. It has been suggested that AT2 receptor
activation counterbalances most effects that Ang II
exerts through the AT1 receptors (Nouet & Nahmias
2000, De Godoy & De Oliveira 2002, Rattan et al.
2002, De Godoy et al. 2003) via the release of inhibi-
tory autacoids (Siragy & Carey 1999, Israel et al.
2000). In our preparations, we never observed inhibi-
tory/relaxant effects of Ang II, although tissues were
able to relax in response of isoproterenol. Because Ang
II binds to its two receptor subtypes, AT1 and AT2,
with a similar affinity, the tissue response is highly
Figure 4 Histogram showing the effects of Ang II (1 nM) in mouse proximal and distal colon in the absence or in the presence
of the Na+ voltage-gated neural channel blocker, TTX (1 lM, n = 5), the muscarinic receptor antagonist, atropine (1 lM, n = 4),
the 5-HT3 receptor antagonist, ondansetron (0.1 lM, n = 3), the NK1 receptor antagonist, SR140333 (0.1 lM, n = 4), the NK2
receptor antagonist, SR48968 (0.1 lM, n = 3), or the nicotinic receptor antagonist, hexamethonium (30 lM, n = 3). Data are
means  SEM and are expressed as percentage of the maximal effect induced by 10 lM CCh. The graphed value for the control
bar is the mean of the control data obtained before each treatment. *P < 0.05 when compared to the respective own control
condition.
Figure 5 Histogram showing the effects of the NK1 receptor
agonist [Sar9, Met(O2)
11]-substance P (1 lM) in the absence
or in the presence of the muscarinic receptor antagonist,
atropine (1 lM, n = 3), and of CCh (10 lM) in the absence
or in the presence of the NK1 receptor antagonist, SR140333
(0.1 lM, n = 3) in mouse distal colon. Data are
means  SEM and are expressed as percentage of the maxi-
mal effect induced by 10 lM CCh. *P < 0.05 when compared
to the respective own control condition.
© 2012 The Authors
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dependent on the relative responsiveness of both recep-
tors (Nouet & Nahmias 2000). Therefore, when the
AT1 subtype is inhibited and the AT2 receptor is free to
interact with Ang II, the AT2-mediated effect becomes
predominant (De Godoy & De Oliveira 2002, Rattan
et al. 2002, De Godoy et al. 2003). In our preparation,
the AT2 receptor antagonist, PD123319, did not affect
Ang II-induced contraction even when the AT1 subtype
receptors are inhibited by losartan. Results from PCR
analysis showed that in control condition, there is not a
detectable expression of AT2 receptors in the proximal
colon, whilst a low expression is evident in the distal
colon. However, it should also be noted that AT2 recep-
tor expression may vary according to tissue conditions,
such as hypoxia or inflammation (Volpe et al. 2003,
Smith & Missailidis 2004). Further studies should
address whether conditions may exist in which AT2
receptor expressions are increased in mouse colon and
whether this is associated with an altered response to
Ang II.
Tetrodotoxin partially antagonized the Ang
II-induced responses in the proximal colon response
suggesting that, in this region, AT1A receptors are
localized both at pre-junctional level, where would
acting modulating neurotransmitter release from the
enteric nerves, and at post-junctional level, likely on
the smooth muscle cells. Indeed, TTX abolished the
effects of Ang II in distal colon, suggesting a prevalent
localization of AT1A receptors at pre-junctional level
in this region. Pre-junctional AT1 receptors, mediating
Ang II effects, have been demonstrated in the guinea-
pig small intestine (Hawcock & Barnes 1993, Wang
et al. 2005), whilst Ang II acts primarily through AT1
receptor located on the musculature in the isolated
human and rat small intestine (Ewert et al. 2006,
Spak et al. 2008) and human oesophagus (Casselbrant
et al. 2007). In our preparations, the contractile
response mediated by pre-junctional AT1A receptor
activation was due to the involvement of cholinergic
and tachykinergic pathways, because it was antago-
nized by atropine and by the selective antagonist of
NK1 receptor, SR140333. Either atropine or
SR140333 reduces Ang II responses to a level not sig-
nificantly different from that measured in the presence
of TTX. Moreover, the observation that, when atro-
pine and SR140333 were applied in combination,
there were not any additive effects, indicates that ace-
tylcholine and tachykinins, likely substance P, are sub-
sequently involved in the mediation of the indirect
responses to Ang II in mouse colon. In particular, we
may suggest that Ang II would induce release of sub-
stance P by enteric nerves, which acting on NK1
receptors, in turn, would induce release of acetylcho-
line, being the final contractile mediator, because, as
already shown (Mule’ et al. 2007, Matsumoto et al.
2009), the contraction induced by a selective NK1
receptor agonist was reduced by atropine, whilst
SR140333 did not affect carbachol-induced muscular
contraction. This conclusion differs from what
observed in guinea-pig small intestine where Ang II
responses are due to activation of angiotensin recep-
tors located neuronally on both cholinergic and
tachykinergic nerves (Hawcock & Barnes 1993). Spe-
cie and tissue differences may account for this discrep-
ancy. Moreover, because 5-HT through 5-HT3
receptor activation is involved in the regulation of
intestinal contractility via modulation of neurotrans-
mitter release either from cholinergic or non-
cholinergic neurones (Tuladhar et al. 2000, Chetty
et al. 2006, Denes et al. 2009), we tested the possibil-
ity 5-HT3 receptor activation could be involved in
Ang II-induced contraction. Such a hypothesis can be
discarded because Ang II effects were not modified by
ondasetron, 5-HT3 receptor antagonists. Indeed, in the
neural circuit activated by Ang II, are not involved
cholinergic interneurones as result by the lack of effi-
cacy of hexamethonium treatment.
The observation that Ang II is able to affect intesti-
nal contractility at a dose similar to the plasma con-
centration (about 0.01 nM) detected in mouse under
basal conditions (Cholewa & Mattson 2005) indicates
that angiotensin receptors in the mouse colon can be
Figure 6 Expression of transcripts encoding the components of RAS, renin, angiotensinogen (AGT), angiotensin-converting
enzyme (ACE), angiotensin receptors (AT1A, AT1B, AT2) in proximal and distal colon preparation. b-Actin (b-Act) primer was
used as a control for cDNA integrity. A 100-bp DNA ladder was used as marker.
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targeted by Ang II formed both at distance (endocrine
action) and locally (paracrine action). The modulation
of the colonic contractility and the consequent impact
on intestinal transit can be one of the physiological
mechanisms by which Ang II would control body fluid
and electrolyte homoeostasis. We are aware that, in
addition to the key mediator octapeptide Ang II, other
AGT fragments have been shown to be biologically
active, such as angiotensin1–7 and angiotensin III and
IV, and this will deserve attention.
In conclusion, the presence in the murine colon of
the components of RAS suggests that Ang II is also
locally generated to control mouse colon motility. In
particular, Ang II positively modulates the spontane-
ous contractile activity via activation of post-junc-
tional and pre-junctional AT1A receptors, the latter
located on the enteric nerves and modulating the
release of tachykinins and acetylcholine. Tachykiner-
gic neurones and cholinergic neurones are sequentially
recruited by Ang II to induce muscular contraction.
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